GILDESS 1/20-1 | Australian Register of Therapeutic Goods | Australia | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

GILDESS 1/20-1
Australia

PharmaCompass Sponsored Ads

Contact Supplier

Norethisterone Acetate

Contact Supplier

Norethisterone Acetate

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

pharmacompass-2-m-2026-03-23

GILDESS 1/20-1

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

31 API Suppliers, 12 USDMF, 4 CEP/COS, 1 JDMF, 4 EU WC, 7 NDC API, 14 Listed Suppliers

31 API Suppliers
12 USDMF
4 CEP/COS
1 JDMF
4 EU WC
7 NDC API
14 Listed Suppliers

DEVELOPMENTS

29 Drugs in Development

29 Drugs in Development

FINISHED DOSAGE FORMULATIONS

247 FDF Dossiers, 120 FDA Orange Book, 104 Europe, 7 Canada, 9 Australia, 7 Listed Dossiers

247 FDF Dossiers
120 FDA Orange Book
104 Europe
7 Canada
9 Australia
7 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL-28 - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-21 - 0.03MG;1.5MG, TABLET;ORAL-21 - 0.03MG;1.5MG, TABLET;ORAL-21 - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-21 - 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE, TABLET;INTRAMUSCULAR, ORAL - 11.25MG/VIAL,N/A;N/A,5MG, INJECTABLE, TABLET;INTRAMUSCULAR, ORAL - 3.75MG/VIAL,N/A;N/A,5MG, CAPSULE;ORAL - 0.02MG;1MG, TABLET, CHEWABLE, TABLET;ORAL - 0.01MG,0.01MG,N/A;1MG,N/A,N/A, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.14MG/24HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.25MG/24HR, TABLET;ORAL - 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 1MG;0.5MG, TABLET;ORAL - 0.0025MG;0.5MG, TABLET;ORAL - 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.01MG,0.01MG;1MG,N/A

TABLET;ORAL-28 - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL-21 - 0.03MG;1.5MG
TABLET;ORAL-21 - 0.03MG;1.5MG
TABLET;ORAL-21 - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL-21 - 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE, TABLET;INTRAMUSCULAR, ORAL - 11.25MG/VIAL,N/A;N/A,5MG
INJECTABLE, TABLET;INTRAMUSCULAR, ORAL - 3.75MG/VIAL,N/A;N/A,5MG
CAPSULE;ORAL - 0.02MG;1MG
TABLET, CHEWABLE, TABLET;ORAL - 0.01MG,0.01MG,N/A;1MG,N/A,N/A
FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.14MG/24HR
FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.25MG/24HR
TABLET;ORAL - 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 1MG;0.5MG
TABLET;ORAL - 0.0025MG;0.5MG
TABLET;ORAL - 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 0.01MG,0.01MG;1MG,N/A

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 5 SPI Pharma, 6 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 3 Kirsch Pharma, 1 Cerata Pharmaceuticals LLP, 1 Dr. Paul Lohmann GmbH & Co. KGaA, 1 ACG Worldwide, 4 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 19 BASF, 2 Clariant, 11 Corel Pharma Chem, 7 DFE Pharma, 1 Doshion Polyscience, 11 Gangwal Chemicals, 1 Gloria Interchem, 1 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures, 4 Ingredion Pharma Solutions, 26 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 1 Nanjing Bold Chemical, 2 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 4 Novo Excipients, 3 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 23 Roquette, 13 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 5 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 5 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

65 Fillers, Diluents & Binders, 49 Coating Systems & Additives, 35 Direct Compression, 32 Granulation, 29 Disintegrants & Superdisintegrants, 26 Solubilizers, 23 Controlled & Modified Release, 22 Thickeners and Stabilizers, 20 Lubricants & Glidants, 16 Taste Masking, 15 Parenteral, 14 Film Formers & Plasticizers, 14 Co-Processed Excipients, 10 Emulsifying Agents, 9 Topical, 8 API Stability Enhancers, 8 Chewable & Orodispersible Aids, 6 Surfactant & Foaming Agents, 6 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 2 Coloring Agents

65 Fillers, Diluents & Binders
49 Coating Systems & Additives
35 Direct Compression
32 Granulation
29 Disintegrants & Superdisintegrants
26 Solubilizers
23 Controlled & Modified Release
22 Thickeners and Stabilizers
20 Lubricants & Glidants
16 Taste Masking
15 Parenteral
14 Film Formers & Plasticizers
14 Co-Processed Excipients
10 Emulsifying Agents
9 Topical
8 API Stability Enhancers
8 Chewable & Orodispersible Aids
6 Surfactant & Foaming Agents
6 Rheology Modifiers
5 Empty Capsules
4 Vegetarian Capsules
2 Coloring Agents

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 47 News #PharmaBuzz

2 Data Compilation #PharmaFlow
47 News #PharmaBuzz

GLOBAL SALES INFORMATION

13 US Medicaid Prescriptions, 3 Regulatory FDF Prices, 7 Annual Reports

13 US Medicaid Prescriptions
3 Regulatory FDF Prices
7 Annual Reports

MARKET PLACE

8 APIs

8 APIs

PATENTS & EXCLUSIVITIES

11 US Patents, 2 US Exclusivities, 1 Health Canada Patents

11 US Patents
2 US Exclusivities
1 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 1 Others

2 EDQM
1 USP
1 Others

$ API Ref.Price (USD/KG) : 3,770 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

9 All

01 1Gedeon Richter Australia Pty Ltd

02 8Sandoz Pty Ltd

filter Active Ingredients Reset all filters

9 All

01 4estradiol (&) estradiol + norethisterone acetate

02 4estradiol + norethisterone acetate

03 1relugolix + estradiol + norethisterone acetate

filter Dosage Form Reset all filters

9 All

01 4Sachet

02 4Transdermal Patch

03 1Blank

filter Brand Name Reset all filters

9 All

01 2Estalis continuous 50/140

02 2Estalis continuous 50/250

03 2Estalis sequi 50/140

04 2Estalis sequi 50/250

05 1Ryeqo

Coral Drugs Norethisterone Acetate

List of Suppliers

Product Main Page

01

Gedeon Richter Australia Pty Ltd

ICMD China

Not Confirmed

Gedeon Richter Australia Pty Ltd

ICMD China

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

relugolix + estradiol + norethisterone acetate

Brand Name : Ryeqo

Dosage Form :

Dosage Strength :

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Sandoz Pty Ltd

ICMD China

Not Confirmed

Sandoz Pty Ltd

ICMD China

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

estradiol + norethisterone acetate

Brand Name : Estalis continuous 50/140

Dosage Form : Transdermal Patch

Dosage Strength : 50MCG

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Sandoz Pty Ltd

ICMD China

Not Confirmed

Sandoz Pty Ltd

ICMD China

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

estradiol (&) estradiol + norethisterone acetate

Brand Name : Estalis sequi 50/140

Dosage Form : Sachet

Dosage Strength : 50MCG

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Sandoz Pty Ltd

ICMD China

Not Confirmed

Sandoz Pty Ltd

ICMD China

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

estradiol (&) estradiol + norethisterone acetate

Brand Name : Estalis sequi 50/250

Dosage Form : Sachet

Dosage Strength : 50MCG

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Sandoz Pty Ltd

ICMD China

Not Confirmed

Sandoz Pty Ltd

ICMD China

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

estradiol + norethisterone acetate

Brand Name : Estalis continuous 50/250

Dosage Form : Transdermal Patch

Dosage Strength : 50MCG

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Sandoz Pty Ltd

ICMD China

Not Confirmed

Sandoz Pty Ltd

ICMD China

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

estradiol (&) estradiol + norethisterone acetate

Brand Name : Estalis sequi 50/140

Dosage Form : Sachet

Dosage Strength : 50MCG

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Sandoz Pty Ltd

ICMD China

Not Confirmed

Sandoz Pty Ltd

ICMD China

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

estradiol (&) estradiol + norethisterone acetate

Brand Name : Estalis sequi 50/250

Dosage Form : Sachet

Dosage Strength : 50MCG

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Sandoz Pty Ltd

ICMD China

Not Confirmed

Sandoz Pty Ltd

ICMD China

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

estradiol + norethisterone acetate

Brand Name : Estalis continuous 50/140

Dosage Form : Transdermal Patch

Dosage Strength : 50MCG

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Sandoz Pty Ltd

ICMD China

Not Confirmed

Sandoz Pty Ltd

ICMD China

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

estradiol + norethisterone acetate

Brand Name : Estalis continuous 50/250

Dosage Form : Transdermal Patch

Dosage Strength : 50MCG

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.